Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

Frontiers in Immunology(2021)10.3389/fimmu.2021.607692Source: DataRank Database

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 258 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access258 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: goldTopics (41)IDs (PubMed, PMC)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Lai Sum Leoh ORCID,Manuel L. Penichet ORCID,Tracy R. Daniels‐Wells ORCID,Pierre V. Candelaria ORCID

Live enrichment

PubMed:33815364 PMC:PMC8010148

National Institutes of Health

Grant: K01CA138559

National Institutes of Health

Grant: K01CA86915

National Institutes of Health

Grant: P30AI028697

National Institutes of Health

Grant: P30CA016042

National Institutes of Health

Grant: R01CA107023

National Institutes of Health

Grant: R01CA196266

NCI NIH HHS

Grant: K01 CA086915

National Institutes of Health

Grant: 5R01CA196266-04

A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL

National Institutes of Health

Grant: 3R01CA107023-03S1

Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma

National Institutes of Health

Grant: 1K01CA138559-01A1

Antibody-mediated Gene Therapy for the Treatment of Cancer

National Institutes of Health

Grant: 5K01CA086915-05

Universal Vectors for the Therapy of Cancer

National Institutes of Health

Grant: 3P30CA016042-35S3

Cancer Center Support Grant

National Institutes of Health

Grant: 5P30AI028697-26

Biostatistics Core

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.607692/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.607692/full

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8010148

repositoryhttps://doaj.org/article/8b4e515bbd214f91a2e4caef799148c5

Europe_PMChttps://europepmc.org/articles/PMC8010148

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsHumansIronReceptors, TransferrinAntigens, CDDrug Evaluation, PreclinicalXenograft Model Antitumor AssaysSignal TransductionAntibody-Dependent Cell CytotoxicityGene Expression Regulation, NeoplasticBiological TransportMolecular Targeted TherapyBiomarkers, TumorAntineoplastic Agents, Immunological

Keywords

CancerTransferrin receptorImmunotherapyCD71Iron DeprivationAntibody-Mediated Effector FunctionsIronImmunologyDrug Evaluation, PreclinicalAntineoplastic Agents, ImmunologicalAntigens, CDCell Line, TumorReceptors, TransferrinBiomarkers, TumorAnimalsHumansMolecular Targeted TherapyAntibody-Dependent Cell CytotoxicityBiological TransportRC581-607Xenograft Model Antitumor AssaysGene Expression Regulation, NeoplasticImmunologic diseases. AllergySignal Transduction

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health